help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guercio, G.
Right arrow Articles by Belgorosky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guercio, G.
Right arrow Articles by Belgorosky, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 3 1162-1169
Copyright © 2002 by The Endocrine Society


Other Original Articles

Relationship between the GH/IGF-I Axis, Insulin Sensitivity, and Adrenal Androgens in Normal Prepubertal and Pubertal Boys

Gabriela Guercio, Marco A. Rivarola, Eduardo Chaler, Mercedes Maceiras and Alicia Belgorosky

Endocrinology Service, Garrahan Pediatric Hospital, Buenos Aires C1245AAM, Argentina

Address all correspondence and requests for reprints to: Dr. Alicia Belgorosky, Laboratorio de Investigación, Hospital de Pediatria Garrahan, C. de los Pozos 1881, Buenos Aires C1245AAM, Argentina. E-mail: . abelgo{at}elsitio.net

Abstract

In girls, but not in boys, pronounced adrenarche and precocious pubarche along with ovarian hyperandrogenism have been related to insulin resistance and reduced fetal growth. However, insulin secretion is increased during puberty in normal boys. The aim of this study was to analyze the possible implication of changes in the GH/IGF-I axis and in insulin sensitivity for the regulation of adrenal androgen secretion of normal prepubertal and adolescent boys. Fifty-six normal boys were divided into the following groups (Gr): Gr1, prepuberty (testicular volume, <4 cc; n = 33); and Gr3, puberty (testicular volume, 4–25 cc; n = 23). Gr1 was subdivided according to age into: Gr1A, early prepuberty (boys younger than 5.9 yr old; n = 16); and Gr1B, late prepuberty (prepubertal boys, 5.9 yr old or older; n = 17). Gr3 was subdivided according to testicular volume into: Gr3A, early puberty (testicular volume, 4–8 cc; n = 13); and Gr3B, late puberty (testicular volume, 10–25 cc; n = 10). To study hormonal changes during the transition between prepuberty and puberty, an additional group, Gr2 (n = 30), was defined by mixing Gr1B and Gr3A. Serum dehydroepiandrosterone sulfate (DHEAS), androstenedione ({Delta}4A), insulin, IGF-I, and glucose were determined after overnight fasting. Insulin sensitivity was estimated by the fasting glucose/insulin (G/I) ratio. There was a close correlation between fasting G/I ratio and QUICKI, a quantitative insulin sensitivity check index.

Mean values for Gr1 and Gr3 as well as their subgroups were compared using t test. In Gr1, the mean fasting G/I ratio was significantly higher, and the mean serum IGF-I, serum DHEAS, and serum {Delta}4A levels were significantly lower than in Gr3 (P < 0.001). Mean fasting G/I ratios in Gr1A and Gr3A were not significantly different from those in Gr1B and Gr3B, respectively, but the fasting G/I ratio in Gr3A was significantly lower than that in Gr1B (P < 0006). Moreover, body mass index (BMI) in Gr3A was significantly higher than that in Gr1B (P < 0.01). On the other hand, mean serum IGF-I levels in Gr1A and Gr3A were significantly lower than those in Gr1B and Gr3B, respectively (P < 0.0001). The mean serum DHEAS level in Gr1A was significantly lower than that in Gr1B (P < 0.01), but no difference was found between Gr3A and Gr3B. The mean serum {Delta}4A in Gr1A was similar to that in Gr1B, but the mean serum {Delta}4A in Gr3A was significantly lower than that in Gr3B (P = 0.0001).

Correlation studies within Gr1, Gr2, and Gr3 were also carried out. There was a significant positive correlation between serum DHEAS and age in Gr1 and Gr2, but not in Gr3. In Gr1, no significant correlation was found between serum DHEAS and fasting G/I ratio or between serum DHEAS and serum IGF-I, suggesting that adrenal steroidogenesis in male prepuberty is independent of insulin sensitivity or peripheral IGF-I. In Gr2, a significant negative correlation (P = 0.01) between serum DHEAS and the fasting G/I ratio was found, but not between serum DHEAS and serum IGF-I. Furthermore, a significant negative correlation between BMI and the fasting G/I ratio was also found. Therefore, changes in insulin sensitivity might be involved in adrenal androgen synthesis during the transition from prepuberty to puberty. Finally, in Gr3, DHEAS was not significantly correlated with the fasting G/I ratio or serum IGF-I. A significant negative correlation between serum {Delta}4A and the fasting G/I ratio was found in Gr2. In Gr2, but not in Gr3, there was a significant negative correlation between the fasting G/I ratio and age (P = 0.03) and between the fasting G/I ratio and serum IGF-I (P = 0.03).

In conclusion, our data support the hypothesis that the GH/IGF-I axis and insulin sensitivity are not involved in the mechanism of adrenarche in boys. Insulin sensitivity and BMI, however, decrease at early puberty rather than at late puberty, and this change could be involved in modulating adrenal androgen steroidogenesis during the transition between late prepuberty and early puberty.

ADRENARCHE IS the increase in adrenal androgen secretion, principally dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS), not accompanied by an increase in cortisol secretion that occurs during prepuberty in higher primates. This event takes place at about 6–8 yr of age in humans (1, 2, 3). The mechanism of this phenomenon is not known. It has been suggested that adrenarche might be secondary to an increment in 17,20-lyase activity by a regulatory effect independent of 17{alpha}-hydroxylase activity (4, 5, 6). We had hypothesized that human adrenarche could be a maturation event secondary to a decrease in 3ß-hydroxysteroid dehydrogenase (3ßHSD) mRNA, and we have suggested that 3ßHSD enzyme activity could modulate adrenal androgen steroidogenesis (7, 8). It has been proposed that hyperinsulinemia causes ovarian hyperandrogenism. Insulin can be shown experimentally to have a variety action on steroidogenesis in humans. This action appears to be directly mediated by insulin receptor. However the occupancy of the IGF-I receptor cannot be ruled out (9).

In girls, pronounced adrenarche and precocious pubarche have been related to insulin resistance with subsequent functional ovarian hyperandrogenism and to reduced fetal growth (10, 11). In boys, information about insulin resistance and precocious pubarche is scarce. A single report concludes that precocious pubarche is not associated with this cluster of endocrine-metabolic abnormalities (12). In contrast to adult women, in adult men, serum DHEAS concentrations correlate positively with insulin sensitivity (13), suggesting a physiological sexual dimorphism.

Consequently, the purpose of this study was to analyze the implication of the GH/IGF-I axis and insulin sensitivity in the regulation of adrenal androgen secretion in normal prepubertal and adolescent boys. We have evaluated the relationship among serum IGF-I, body mass index (BMI), fasting serum glucose/insulin ratio (fasting G/I ratio) as an indirect marker of insulin sensitivity, and adrenal androgens in 56 normal boys during early and late prepuberty as well as during pubertal development.

Subjects and Methods

Subjects

Serum samples were collected from patients attending a general pediatric hospital for ambulatory nonendocrine disorders such as strabismus, inguinal hernia, skeletal congenital defects, etc. Serum samples were taken from blood drawn for routine surgical check up. A pediatric endocrinologist was present during blood sampling to obtain oral consent from the parents. Clinical examination was carried out by the same trained pediatric endocrinologist for evaluation of Tanner’s stage of sexual development and assessment of testicular volume, as well as height, BMI, and general well-being. Subjects were included in the study according to the following criteria. Height equal or higher than -1.5 SD score, BMI between 15–85 percentiles of a population of Hispanic subjects older than 5 yr (14), and weight for height between 80–110% of normal for the Argentinean population in subjects less than 5 yr old. The protocol was approved by the research committee of the Garrahan Pediatric Hospital.

The study included 56 normal boys whose clinical characteristics are listed in Table 1Go. Subjects were divided according to testicular volume (TV). Group 1 (Gr1) included 33 prepubertal subjects with TV less than 4 cc. To analyze early and late prepubertal periods, Gr1 was subdivided into two subgroups according to median chronological age (5.9 yr): subjects below the median, Gr1A (n = 16) and subjects at the median or above, Gr1B (n = 17). Gr3 included 23 subjects with TV between 4–25 cc. They were subdivided into 2 subgroups according to TV: subjects with TV between 4–8 cc (Gr3A, early puberty; n = 13) and subjects with TV between 10–25 cc (Gr3B, late puberty; n = 10). To study hormonal changes during the transition between prepuberty and puberty, an additional group, Gr2 (n = 30), was defined by mixing the late prepuberty and the early puberty subgroups.


View this table:
[in this window]
[in a new window]
 
Table 1. Clinical groups, number of subjects, chronological age (CA), height (HT) SD score, body mass index (BMI), and testicular volume (TV)

 
Methods

Serum DHEAS was determined with the Immulite assay (Diagnostic Products, Los Angeles, CA); the sensitivity was 0.05 µmol/liter, and the interassay coefficient of variation ranged from 8.1–15%. Serum androstenedione ({Delta}4A) was determined by RIA (Diagnostic Systems Laboratories, Inc., Webster, TX); the assay sensitivity was 0.10 nmol/liter, and the interassay coefficient of variation ranged from 7–9.8%. Serum IGF-I was determined by RIA after acid-ethanol extraction of serum, as previously reported (15). Insulin was determined by the Imx sys lens (Abbott Laboratories, Chicago, IL); the assay sensitivity was 1.0 µU/ml, and the interassay coefficient of variation ranged from 3.8–4.5%.

Serum glucose was determined by a Hitachi 911 autoanalyzer. As previously reported (16, 17), the fasting G/I ratio is a useful measure of insulin sensitivity. Furthermore, as a correlation between the quantitative insulin sensitivity check index (QUICKI = 1/log I + log G) and the euglycemic glucose clamp has been reported, QUICKI has been proposed as a simple and accurate method to assess insulin sensitivity (18). To validate the fasting G/I ratio (milligrams per 10-4 U) as an indirect marker of insulin sensitivity in our normal subjects, we studied the correlation of this marker with QUICKI. We found a correlation coefficient of 0.91 (P < 0.0001; Fig. 1Go) Therefore, in this study insulin sensitivity is estimated by the fasting G/I ratio.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Relationship between the fasting G/I ratio and QUICKI in the entire population of samples. A highly significant correlation between these two ways of estimating insulin sensitivity was found.

 
Statistical analyses

All statistical analyses were performed using Statistix 7 (Analytical software, Tallahassee, FL). Unpaired t test was employed to assess mean value differences. Simple linear regression analysis between several pairs of variables was carried out. Furthermore, Pearson’s correlation was calculated to compute a correlation matrix for several variables.

Results

The mean (±SD) fasting G/I ratio, serum IGF-I, DHEAS, and {Delta}4A in Gr1, Gr2, and Gr3 are shown in Table 2Go. In Gr1, the fasting G/I ratio was significantly higher (P < 0.001), and serum IGF-I, serum DHEAS and serum {Delta}4A were significantly lower than in Gr3 (P < 0.001). There was no difference between early (Gr1A) and late prepuberty (Gr1B) fasting G/I ratios or between early puberty (Gr3A) and late puberty (Gr3B) fasting G/I ratios. However, the fasting G/I ratio decreased between late prepuberty and early puberty. We also found that BMI increased significantly in Gr3A compared with Gr1B (Table 1Go) at a time when a significant decrement in the fasting G/I ratio was found.


View this table:
[in this window]
[in a new window]
 
Table 2. Fasting G/I ratio, serum IGF-I, serum DHEAS, and serum {Delta}4A in groups 1, 1A, 1B, 2, 3, 3A, and 3B

 
The mean serum IGF-I level was significantly higher in Gr1B than in Gr1A (P < 0.01). Moreover, the mean serum IGF-I level increased significantly from Gr3A to Gr3B (P = 0.0001).

The mean serum DHEAS level in Gr1B was significantly higher than in Gr1A (P < 0.02). However, no difference between Gr3A and Gr3B was found. These data indicated that serum DHEAS levels increase during the transition from late prepuberty (Gr1B) to early puberty (Gr3A). Serum {Delta}4A levels were similar in Gr1A and Gr1B. During puberty, in contrast to DHEAS, serum {Delta}4A increased significantly from Gr3A to Gr3B (P = 0.0001).

The relationships between serum DHEAS and chronological age, fasting G/I ratio, and serum IGF-I in Gr1, Gr2, and Gr3 are shown in Fig. 2Go. The serum DHEAS level increased significantly with age in Gr1 and Gr2. However, no significant increase with age was found in Gr3, suggesting that DHEAS serum levels increase in late prepuberty and early puberty. There was no significant correlation between serum DHEAS and fasting G/I ratios or between serum DHEAS and serum IGF-I in Gr1, suggesting that during prepuberty insulin and the GH/IGF-I axis are not involved in adrenal androgen steroidogenesis. However, a significant negative correlation (P = 0.01) between serum DHEAS and the fasting G/I ratio, but not between serum DHEAS and serum IGF-I, was found in Gr2. This suggests that peripheral insulin sensitivity, but not extraadrenal IGF-I, might influence adrenal androgen steroidogenesis during the transition between late prepuberty and early puberty. Finally, no correlation was found between serum DHEAS and fasting G/I or between serum DHEAS and IGF-I in Gr3.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. Upper panel, Relationship between serum DHEAS and chronological age (CA). A significant positive correlation was found in Gr1 and Gr2, but not in Gr3. Middle panel, Relationship between serum DHEAS and the fasting G/I ratio. A significant negative correlation was found in Gr2. Lower panel, Relationship between serum DHEAS and serum IGF-I. No correlation was found in any group.

 
The relationships between serum {Delta}4A and chronological age, fasting G/I ratio, and serum IGF-I in Gr1, Gr2, and Gr3 are shown in Fig. 3Go. In Gr1, no significant correlation between serum {Delta}4A levels and chronological age, fasting G/I ratio or serum IGF-I was observed. However, serum {Delta}4A increased significantly with age in Gr2 and Gr3, suggesting that serum {Delta}4A increases during transition from prepuberty to puberty as well as during the rest of pubertal development. A significant negative correlation between serum {Delta}4A and fasting G/I was only found in Gr2, suggesting again that there is an influence of insulin sensitivity on adrenal androgen steroidogenesis in early puberty. No significant correlation between serum {Delta}4A and serum IGF-I was found in any of the groups, suggesting that peripheral IGF-I is not involved in adrenal androgen steroidogenesis during prepubertal and pubertal development.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 3. Upper panel, Relationship between serum {Delta}4A and chronological age (CA). A significant positive correlation was found in Gr2 and Gr3. Middle panel, Relationship between serum {Delta}4A and the fasting G/I ratio. A significant negative correlation was found in Gr2. Lower panel, Relationship between serum {Delta}4A and serum IGF-I. No correlation was found in any group.

 
The relationships between the fasting G/I ratio and chronological age and between the fasting G/I ratio and serum IGF-I in Gr1, Gr2, and Gr3 are shown in Fig. 4Go. No significant correlation between the fasting G/I ratio and chronological age was found in Gr1, suggesting that insulin sensitivity does not change during prepuberty. On the other hand, a significant negative correlation between serum IGF-I and the fasting G/I ratio was found in Gr1 (P = 0.05). In Gr2, the fasting G/I ratio correlated negatively and significantly with chronological age (P = 0.03), serum IGF-I (P = 0.03), and BMI (r = -0.37; P = 0.03; data not shown in figures), suggesting that BMI and insulin sensitivity are modified in early puberty, and that the GH/IGF-I axis is involved in this change. Finally, no significant correlation between the fasting G/I ratio and chronological age or BMI (data not shown) was observed in Gr3. Furthermore, no significant correlation between the fasting G/I ratio and serum IGF-I was found in Gr3.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 4. Upper panel, Relationship between the fasting G/I ratio and chronological age (CA). A significant negative correlation was found in Gr2. Lower panel, Relationship between the fasting G/I ratio and serum IGF-I. A significant negative correlation was found in Gr1 and Gr2.

 
To sort out the effect of age on simple regression analysis of the different parameters studied, Pearson multiple correlation analysis was carried out. Table 3Go shows the correlation matrix of this analysis. It confirmed that there was absence of correlation either between serum DHEAS and the fasting G/I ratio or between serum DHEAS and serum IGF-I during prepuberty (Gr1). Table 3Go also shows that there was a significant negative correlation between serum DHEAS and the fasting G/I ratio, but not between serum DHEAS and serum IGF-I, during the transition from prepuberty to puberty (Gr2). Furthermore, there was a significant negative correlation between BMI and the fasting G/I ratio and a significant positive correlation between BMI and DHEAS in Gr2. On the other hand, no significant correlations were found during puberty (Gr3), except for serum IGF-I and chronological age.


View this table:
[in this window]
[in a new window]
 
Table 3. Pearson correlation matrix

 
Discussion

In the present study we have examined the implications of serum insulin and the GH-IGF-I axis on adrenal androgen steroidogenesis in normal prepubertal and pubertal boys. We have used the fasting G/I ratio as an indirect marker of insulin sensitivity. A single determination of glucose and insulin levels is not the best method for assessing insulin sensitivity. However, more accurate techniques such as the hyperinsulinemic euglycemic glucose clamp technique and the minimal model analysis of a frequently sampled iv glucose tolerance test are either very labor intensive or require large blood sampling. Therefore, they are not feasible for screening large populations of normal children and adolescents (19, 20). That’s why the fasting G/I ratio has been validated as a clinically useful parameter for measuring insulin sensitivity in women with polycystic ovary syndrome (16). Furthermore, it has been reported that the fasting G/I ratio is a useful measure of insulin resistance in girls with premature adrenarche (17). In the present study we checked the usefulness of the measurement of serum glucose and insulin in the fasting state by calculating QUICKI in every sample. QUICKI has been shown to be an accurate method for assessing insulin sensitivity in humans (18). We found a very high correlation between the fasting G/I ratio and QUICKI.

Insulin can be shown experimentally to have a variety of direct actions on steroidogenesis in humans (21). Hyperinsulinism and insulin resistance were present in small for gestational age girls with exaggerated adrenarche, and it had been speculated that insulin resistance might be responsible for the initially reduced growth and subsequently exaggerated adrenarche in these girls (11). In boys, pronounced adrenarche and precocious pubarche were not found to be associated to this cluster of endocrine and metabolic abnormalities in the only study available (12). However, several reports have described an increment in insulin secretion in early puberty as a compensatory response to reductions in insulin sensitivity in normal adolescents of the two sexes (22, 23, 24). In our study we found that, as previously described (25, 26), serum DHEAS levels increased during prepuberty, but we also showed that there was an increment during the transition from late prepuberty to early puberty. However, the fasting G/I ratio did not increase during prepuberty. These results suggest that insulin is not involved in the development of normal human adrenarche during the prepubertal years in boys. As we previously described, adrenarche might be an adrenal maturation event secondary to a decrement in 3ßHSD activity (7, 8) along with an increment in 17,20-lyase activity by a regulatory effect independent of 17{alpha}-hydroxylase activity (5, 6).

The fasting G/I ratio increased from late prepuberty to early puberty, and it remained unchanged during late puberty. We also found a significant negative correlation between the fasting G/I ratio and serum DHEAS when late prepubertal and early pubertal subjects were analyzed together. The fact that the decrement in insulin sensitivity is associated with an increment in serum DHEAS during the transition to early puberty suggests that peripheral insulin is involved in adrenal androgen steroidogenesis after adrenarche in normal adolescent boys. Even though this negative correlation does not necessarily imply a cause-effect relationship, published evidence suggests than insulin amplifies 17{alpha}-hydroxycorticosteroid intermediates response to ACTH (27). On the other hand, in polycystic ovary syndrome, a condition marked by insulin insensitivity, adrenal hyperandrogenism is often associated with ovarian hyperandrogenism (28). However, our data differ from the report of Potau et al. (12). In that study insulin sensitivity increased with advanced puberty. However, Potau’s study was performed in short normal children. In our study the mean height SD scores were near 0 in all groups, and ranges varied from -1.5 to 2.

Even though serum IGF-I levels increased from early prepuberty to late prepuberty and also during the rest of pubertal development, no correlation between serum DHEAS and serum IGF-I levels was found. Therefore, serum IGF-I is probably not involved in the regulation of adrenal androgen steroidogenesis. According to a previous report (29), there is a significant negative correlation between serum IGF-I and insulin levels in prepuberty and early puberty. The pattern of IGF-I and insulin levels may be related to changes in GH release. However, the fact that the main change in insulin sensitivity occurs in early puberty, and it remains unchanged in late puberty, when the most significant increment in serum IGF-I takes place, suggests that other factors, which are relevant in late puberty, might affect insulin sensitivity. Indeed, it was previously reported that BMI was the best predictor of insulin sensitivity in normal pubertal boys (30, 31). In line with these reports, we found that BMI increased significantly in early puberty when the fasting G/I ratio decreased. The increment in BMI in early puberty could be secondary to an increment in IGF-I (32) along with moderate increases in testicular T. In late puberty, however, at a time when serum IGF-I and T levels reach their maximum, there was no further increase in BMI or in insulin resistance. It is possible that T-induced lipolysis (33, 34, 35) prevents further increments in body adiposity.

Differences in the pattern of changes in serum {Delta}4A and DHEAS levels were observed during prepuberty and puberty. Serum {Delta}4A did not change throughout prepuberty, but increased from late prepuberty to early puberty and during puberty. These increments might be secondary to an increase in testicular secretion of {Delta}4A. Similarly to what was observed with serum DHEAS, we found a significant negative correlation between the fasting G/I ratio and serum {Delta}4A when late prepubertal and early pubertal boys were analyzed together, suggesting again that insulin regulates adrenal androgen steroidogenesis in early puberty. Our results also suggest that peripheral IGF-I is not involved in {Delta}4A synthesis.

In summary, the findings of this study indicate that the GH/IGF-I axis and insulin resistance are not involved in the mechanism of adrenarche during prepuberty in boys. We also found that in normal boys, insulin sensitivity decreases at early puberty rather than at late puberty, following changes in BMI. It is suggested that the increment in T secretion characteristics of late puberty offsets possible effects of the GH/IGF-I axis on body adiposity. These data suggest that peripheral insulin could be involved in adrenal androgen steroidogenesis, particularly during early puberty. As this evidence is partially based on correlations, additional studies are necessary to confirm these findings.

Acknowledgments

The contributions of D. Chirico and L. Del Rio are acknowledged. We thank the National Pituitary Agency for the generous supply of IGF-I RIA reagents.

Footnotes

This work was supported by grants from CONICET, FONCYT, and Ministerio de Salud (Beca Carrillo-Oñativia) of Argentina.

Abbreviations: {Delta}4A, Androstenedione; BMI, body mass index; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone sulfate; G/I, glucose/insulin; Gr, group; 3ßHSD, 3ß-hydroxysteroid dehydrogenase; QUICKI, quantitative insulin sensitivity check index.

Received January 19, 2001.

Accepted December 5, 2001.

References

  1. Sklar CA, Kaplan SL, Grumbach MM 1980 Evidence for dissociation between adrenarche and gonadarche studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 51:548–556[Abstract/Free Full Text]
  2. Parker LN 1991 Adrenarche. Endocrinology Metab Clin North Am 20:71–78[Medline]
  3. Migeon CJ, Keller AR, Laurence B, Shepard THI 1957 Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex, day to day and diurnal variations. J Clin Endocrinol Metab 17:1051–1056
  4. Onoda M, Hall PF 1982 Cytochrome b5 stimulates purified testicular microsomal cytochrome P-450 (C21 side-chain cleavage). Biochem Biophys Res Commun 108:454–460[Medline]
  5. Shinzawa K, Kominami S, Takemori S 1985 Studies on cytochrome P450 (P45017{alpha}, lyase) from guinea pig adrenal microsomes: dual function of a single enzyme and effect of cytochrome b5. Biochim Biophys Acta 833:151–160[Medline]
  6. Lin D, Black SM, Nagahama Y, Miller WI 1993 Steroid 17{alpha}-hydroxylase and 17,20 lyase activities of P450c17. Contributions of serine 106 and P450 reductase. Endocrinology 132:2498–2506[Abstract/Free Full Text]
  7. Dardis A, Saraco N, Rivarola MA, Belgorosky A 1999 Decrease in the expression of the 3ß-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty. Implications to the mechanism of adrenarche. Pediatr Res 45:384–388[Medline]
  8. Dardis A, Saraco N, Berensztein E, Rivarola MA, Belgorosky A 1999 Implicancias de la enzima 3ß-hidroxiesteroide dehidrogenasa (3ßHSD) en la síntesis de andrógenos en la adrenal humana. Medicina 59:1–4
  9. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800[Abstract/Free Full Text]
  10. Ibáñez L, Potau N, Francois I, De Zegher F 1998 Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 83:3558–3562[Abstract/Free Full Text]
  11. Ibáñez L, Potau N, Marcos MV, Francois I, De Zegher F 1999 Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 84:4739–4741[Abstract/Free Full Text]
  12. Potau N, Ibáñez L, Riqué S, Sanchez-Ufarte C, De Zegher F 1999 Pronounced adrenarche and precocious pubarche in boys. Horm Res 51:238–241[CrossRef][Medline]
  13. Nestler JE, Beer NA, Jakubowicz DJ, Beer RM 1994 Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. J Clin Endocrinol Metab 78:549–554[Abstract]
  14. Rosner B, Prineas R, Loggie J, Daniels SR 1998 Percentiles for body mass index in U.S. children 5 to 17 years of age. J Pediatr 132:211–222[CrossRef][Medline]
  15. Belgorosky A, Rivarola MA 1999 Insulin-like growth factor binding protein (IGFBP)-3 bound and IGFBP-3 bound IGF-II in growth hormone deficiency. Horm Res 52:60–65[CrossRef][Medline]
  16. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694–2698[Abstract/Free Full Text]
  17. Unguin P, Saenger P, Di Martino-Nardi J 1999 Fasting glucose insulin ratio: a useful measure of insulin resistance in girls with premature adrenarche. Pediatr Res 45:99A
  18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402–2410[Abstract/Free Full Text]
  19. Laakso M 1993 How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959–965[Abstract/Free Full Text]
  20. American Diabetic Association 1997 Consensus Development Conference on Insulin Resistance: 5–6 November 1997. Diabetes Care 21:310–314[Medline]
  21. Nestler JE, Strauss III JF 1991 Insulin as an effector of human ovarian and adrenal steroid metabolism. Endocrinol Metab Clin North Am 20:807–823[Medline]
  22. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV 1989 Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114:963–967[CrossRef][Medline]
  23. Bloch CA, Clemons P, Sperling MA 1987 Puberty decreases insulin sensitivity. J Pediatr 110:481–487[CrossRef][Medline]
  24. Potau N, Ibáñez L, Riqué S, Carrascosa A 1997 Pubertal changes in insulin and peripheral insulin sensitivity. Horm Res 48:219–226[Medline]
  25. Forest MG 1989 Physiological changes in circulating androgens. In: Forest MG, ed. Androgens in childhood. Pediatric and adolescent endocrinology. Basel: Karger; 104–129
  26. Belgorosky A, Rivarola MA 1988 Progressive increase in non-sex hormone-binding globulin-bound testosterone and estradiol from infancy to late prepuberty in girls. J Clin Endocrinol Metab 67:234–237[Abstract/Free Full Text]
  27. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M 1996 Insulin infusion amplifies 17{alpha}-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81:881–886[Abstract]
  28. Azziz R, Black V, Hines GA, Fox LM, Boots LR 1998 Adrenal androgen excess in the polycystic ovary syndrome sensitivity and responsibility of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 83:2317–2323[Abstract/Free Full Text]
  29. Smith CP, Dunger DB, Williams AJK, Taylor AM, Perry LA, Gale EAM, Preece MA, Savage MO 1989 Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab 68:932–937[Abstract/Free Full Text]
  30. Cook JS, Hoffman RP, Stene MA, Hansen JR 1993 Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab 77:725–730[Abstract]
  31. Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH 1995 Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab 80:172–178[Abstract]
  32. Wabitsch M, Hauner H, Heinze E, Teller WM 1995 The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism 44(Suppl 4):45–49
  33. Marin P, Krotkiewski M, Bjorntorp P 1992 Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1:329–336[Medline]
  34. Marin P, Oden B, Bjorntorp P 1995 Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239–243[Abstract]
  35. Dieudonne MN, Pecquery R, Leneveu, Giudicelli Y 2000 Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidences for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor {gamma}2. Endocrinology 141:649–656[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
L. Shi, S. A Wudy, A. E Buyken, M. F Hartmann, and T. Remer
Body fat and animal protein intakes are associated with adrenal androgen secretion in children
Am. J. Clinical Nutrition, November 1, 2009; 90(5): 1321 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
Z Hochberg
Juvenility in the context of life history theory
Arch. Dis. Child., June 1, 2008; 93(6): 534 - 539.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. I. Hernandez, A. Martinez, T. Capurro, V. Pena, L. Trejo, A. Avila, T. Salazar, S. Asenjo, G. Iniguez, and V. Mericq
Comparison of Clinical, Ultrasonographic, and Biochemical Differences at the Beginning of Puberty in Healthy Girls Born Either Small for Gestational Age or Appropriate for Gestational Age: Preliminary Results
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3377 - 3381.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Guercio, M. A. Rivarola, E. Chaler, M. Maceiras, and A. Belgorosky
Relationship between the Growth Hormone/Insulin-Like Growth Factor-I Axis, Insulin Sensitivity, and Adrenal Androgens in Normal Prepubertal and Pubertal Girls
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1389 - 1393.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield
Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5604 - 5609.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guercio, G.
Right arrow Articles by Belgorosky, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guercio, G.
Right arrow Articles by Belgorosky, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals